💊 This morning, EU negotiators reached an agreement on the #PharmaPackage, the first major update of EU pharmaceutical rules in 20+ years.
While the final deal opens doors to more equitable access to cancer medicines, it does not go far enough to truly lower costs.
➡️ buff.ly/K7LNLYh
It was a very long journey, and the last mile was the hardest, but we now have a deal. Lots of positives, but also some disappointment.
www.vitalsigns.news/eu-reaches-l...
#PharmaPackage #eu2025dk #DanishPresidency
💊 Talks between the European Commission, Parliament, and governments on the #PharmaPackage are continuing tomorrow.
This landmark legislation could unlock better access to affective and affordable cancer drugs - but only if negotiators put health over profit.
💊 Talks between EU legislators on the EU's #PharmaPackage - the first major overhaul of the EU pharmaceutical framework since 2004 - are continuing today.
This is a landmark reform that could finally fix gaps in cancer patients' access to affordable medicines. Our 5️⃣ recommendations: buff.ly/HQAgD7q
"The Council's position lacks the ambition to truly improve cancer patients’ access to affordable medicines."
#PharmaPackage talks officially began this month. This landmark law could boost access - if negotiators put health over profit, says ECL's @tomamikalauskaite.bsky.social 👇
💊 Talks between the European Commission, Parliament, and governments on the #PharmaPackage kick off today.
This landmark legislation could unlock better access to affective and affordable cancer drugs - but only if negotiators put health over profit.
Read our take on LinkedIn: buff.ly/MJmcRAP
A drawing featuring pills of various sizes falling into an open pill-bottle
📢 The Council has agreed its position on the #PharmaPackage — the first major update to EU pharma rules since 2004.
The aim: better access to medicines and stronger innovation
Next step: negotiations with the EU Parliament
Find out more: europa.eu/!3rFVck
#EUHealth #AMR
💊 As EU negotiates the #PharmaPackage, we urge: put patients before profits.
💶 High drug prices are blocking access & straining healthcare.
Incentives must serve public health, not block it.
📝 Joint statement 👉 www.aim-mutual.org/mediaroom/ec...